Related by context. All words. (Click for frequent words.) 73 thyroglobulin 72 F FDG PET 71 immunohistochemical analysis 71 FDG-PET/CT 71 guaiac 71 immunochemical 70 SLNB 70 CIN2 + 70 immunohistochemical 70 chest radiographs 70 NMP# 70 scintigraphic 70 adenomatous polyps 70 cytologic 69 catheter angiography 69 pelvic ultrasound 69 fine needle aspiration 69 serum PSA 69 serum thyroglobulin 69 endometrial biopsy 69 pCR 69 pulmonary angiography 69 ASCUS 68 TRUS 68 pelvic lymphadenectomy 68 transurethral resection 68 optical colonoscopy 68 cytological 68 pathologic diagnosis 68 urine albumin 68 TMPRSS2 ERG 68 histopathological 68 core needle biopsy 68 sensitivity specificity 68 prostate carcinoma 68 thyroid nodules 68 cTnT 68 specific antigen PSA 68 digital rectal examination 68 #F FDG PET 68 microsatellite instability 68 spirometric 68 prostate cancer CaP 68 HER2 expression 68 renal cell carcinomas 68 epithelial tumors 68 needle aspiration 67 CIN3 67 immunohistochemical staining 67 intravesical therapy 67 helical CT 67 urothelial carcinoma 67 lobular carcinoma 67 conventional coronary angiography 67 transesophageal echocardiography 67 malignant lesions 67 duplex ultrasonography 67 OGTT 67 cystoscopic 67 detecting colorectal cancer 67 radical nephrectomy 67 sentinel lymph node biopsy 67 grade cervical intraepithelial 67 cervical carcinoma 67 PSA nadir 67 intraobserver 67 conventional angiography 67 arteriography 67 Gram stain 67 troponins 67 Hurthle cell 67 advanced adenomas 67 advanced neoplasia 67 mammographically 67 pathologic examination 67 FDG uptake 67 bronchoalveolar lavage 67 transabdominal 67 transthoracic 67 histological subtype 67 bone scintigraphy 67 breast carcinoma 67 cardiac perfusion 67 calculated creatinine clearance 67 ELISpot 66 micrometastasis 66 coronary stenosis 66 cardiac troponin 66 Cervista HPV HR 66 mucinous 66 leiomyomas 66 nodal metastases 66 Immunohistochemical staining 66 glomerular filtration 66 SUVmax 66 IGRAs 66 malignant nodules 66 EUS FNA 66 histopathologic findings 66 hamartomas 66 immunostaining 66 histologic examination 66 EBUS FNA 66 atypical hyperplasia 66 PCa 66 lung nodules 66 K ras mutations 66 SLN biopsy 66 malignant polyps 66 guaiac test 66 histopathologic examination 66 Papillary 66 venography 66 ischemic lesions 66 FDG PET 66 Radical prostatectomy 66 histopathologic 66 MGd 66 D dimer 66 induced sputum 66 HGPIN 66 KRAS mutation 66 florbetaben 66 NMIBC 66 upper endoscopy 66 lymphadenectomy 66 HER2 overexpression 65 hepatocellular carcinomas 65 Prostate Specific Antigen PSA 65 neoplasm 65 arthrography 65 cystoscopy 65 spiral computed tomography 65 R0 resection 65 abnormal cytology 65 neoplasias 65 pT3 65 transrectal ultrasound guided 65 cTnI 65 chest radiography 65 coronary arteriography 65 stent stenosis 65 surgical biopsy 65 mediastinoscopy 65 Immunohistochemistry 65 ^ sup #m 65 HER2 positive cancers 65 metaplasia 65 TMPRSS2 ERG fusion 65 #F FDG 65 dysuria 65 Histologic 65 aminotransferases 65 Cytogenetic 65 ovarian carcinoma 65 adrenalectomy 65 precursor lesions 65 rheumatoid factor 65 preoperative diagnosis 65 diagnostic modality 65 excisional biopsy 65 colorectal neoplasms 65 lung nodule 65 FDG PET imaging 65 hematopoietic cancers 65 urodynamic 65 conventional cytology 65 estrogen receptor ER 65 methacholine challenge 65 NGAL 65 Doxil ® 65 TURBT 65 β blockers 65 ELISPOT 65 prostate TURP 65 oncologic outcomes 65 carotid stenosis 65 renal tumors 65 HER2 amplification 65 #.#ng/ml 65 assay ELISA 65 eosinophil count 65 myocardial necrosis 65 pleural fluid 65 DCE MRI 65 intestinal metaplasia 65 axillary lymph node 65 cardiac troponin T 65 abdominal ultrasound 65 sonographically guided 65 urine dipstick 65 Hemoccult II 65 nodal metastasis 65 metastatic lymph nodes 65 chemosensitivity 65 liver metastasis 65 hyperplastic polyps 65 Adjuvant chemotherapy 65 histologic subtype 65 tumorigenicity 65 exhaled nitric oxide 65 prognostic biomarker 65 Squamous 64 colorectal carcinoma 64 colorectal adenoma 64 wedge resection 64 Adenomas 64 carcinoembryonic antigen 64 endocervical 64 haematologic 64 B7 H3 64 PSADT 64 colonography 64 sestamibi 64 scintigraphy 64 BRCA2 mutation carriers 64 antibody titer 64 colorectal carcinomas 64 sonographically 64 immunochemical fecal occult 64 Prostate specific antigen 64 invasive coronary angiography 64 RQ PCR 64 esophagogastroduodenoscopy 64 angiographically 64 HRCT 64 MR spectroscopy 64 histologically 64 axillary node dissection 64 lymphovascular invasion 64 sputum cytology 64 transvaginal sonography 64 perfusion imaging 64 pT2 64 QT QTc 64 invasive carcinomas 64 Prostate Specific Antigen 64 coronary CTA 64 HNSCC 64 alanine aminotransferase ALT 64 advanced adenoma 64 nonmelanoma skin cancers 64 NMP# assay 64 ductal cancer 64 serum IgE 64 breast carcinomas 64 Subgroup analysis 64 benign lesions 64 follicular thyroid cancer 64 renal artery stenosis 64 stratifying patients 64 tPSA 64 T SPOT.TB test 64 squamous intraepithelial lesions 64 intima media thickness 64 TOP2A 64 postoperative morbidity 64 VCUG 64 interobserver 64 qRT PCR 64 immunohistochemistry IHC 64 Postoperative complications 64 immunoblot 64 extracapsular extension 64 SGPT 64 metabolite concentrations 64 quantitative reverse transcriptase 64 PCR assay 64 urography 64 pulmonary metastases 64 metastatic malignant 64 Leydig cell 64 adjuvant therapies 64 microalbumin 64 HCV antibody 64 sentinel node 64 CT angiography 64 PAP smear 64 anti JCV antibodies 64 histological examination 64 renal biopsy 64 locoregional recurrence 64 Endometrial 64 serologic testing 64 IgA deficiency 64 chemoradiation therapy 64 histologic 64 karyotyping 64 creatinine ratio 64 liver histology 64 prognostically 64 MMSE score 64 posttreatment 64 endoscopic ultrasonography 64 lung resections 64 serum cortisol 64 serologic 64 enhanced sonography 64 sonographic findings 64 cytokeratin 64 gadolinium enhanced 64 hematuria 64 AST ALT 64 radiographic findings 64 orchiectomy 63 intact parathyroid hormone 63 aminotransferase 63 tumor histology 63 adnexal mass 63 endometrioid 63 sentinel nodes 63 HBsAg 63 pretest probability 63 ultrasound elastography 63 AGHD 63 nephrectomy 63 serum prostate 63 hematological parameters 63 transcranial Doppler 63 promoter methylation 63 histologic subtypes 63 ultrasonographic 63 lymph node dissection 63 transient elastography 63 postoperative chemotherapy 63 cytologic examination 63 LV dysfunction 63 Bonferroni correction 63 axillary dissection 63 lactate dehydrogenase LDH 63 Fine needle aspiration 63 protein excretion 63 axillary lymph nodes 63 gene amplification 63 pentoxifylline 63 cytoreductive surgery 63 chlamydial infection 63 immunohistochemistry 63 microvessel density 63 interobserver agreement 63 elevated LDH 63 postoperative complication 63 chromosomal aberrations 63 MSCT 63 cytologically 63 troponin T 63 Inhibin B 63 choroidal neovascularization 63 cellularity 63 carotid IMT 63 myeloperoxidase 63 fluorodeoxyglucose positron emission tomography 63 Doppler sonography 63 T SPOT.TB 63 Histologically 63 osteoid 63 sarcomatoid 63 colorectal neoplasia 63 situ LCIS 63 Annexin V 63 lymphocytosis 63 Biopsies 63 genotypic resistance 63 biopsy specimens 63 extracolonic findings 63 leukocytosis 63 sentinel node biopsy 63 progesterone receptor PR 63 allogeneic HSCT 63 BRAF V#E mutation 63 biochemical recurrence 63 leiomyoma 63 preoperative chemotherapy 63 normal karyotype 63 lymph node metastases 63 biopsied tissue 63 adenomatous 63 RECIST Response Evaluation Criteria 63 tissue biopsies 63 Amniocentesis 63 tumoral 63 neoadjuvant therapy 63 ERalpha 63 colonic polyps 63 ovarian malignancy 63 BCR ABL mutations 63 Immunohistochemical 63 barium enema 63 urothelial cancer 63 hemoglobin hematocrit 63 squamous 63 Radiofrequency ablation 63 cytoreduction 63 adjuvant radiation 63 adjuvant radiotherapy 63 epithelial ovarian cancer 63 multidetector row 63 cytoreductive nephrectomy 63 severe neutropenia 63 differentiated thyroid 63 morphometric vertebral fractures 63 #ß 63 Her2/neu 63 hepatectomy 63 seminoma 63 colorectal liver metastases 63 alkaline phosphatase ALP 63 colonoscopy flexible sigmoidoscopy 63 relapsed MM 63 PCA3 scores 63 lactate dehydrogenase 63 galiximab 63 Rh factor 63 immunoreactivity 63 serologic tests 63 preoperative PSA 63 micronuclei 63 radical retropubic prostatectomy 63 artery stenosis 63 node metastases 63 ductal carcinomas 63 immunofluorescent 63 methylation markers 63 albumin excretion rate 63 bladder tumors 63 radioiodine therapy 63 ELISAs 63 debulking surgery 63 cervical cytology 63 atypia 62 SpCO 62 tuberculin skin test 62 thyroidectomy 62 multivariate analyzes 62 radical cystectomy 62 clinicopathological features 62 mCi 62 p# antigen 62 enhanced MR angiography 62 invasive lobular carcinoma 62 nondiagnostic 62 specific antigen 62 endosonography 62 T1 weighted images 62 nonalcoholic steatohepatitis NASH 62 TPMT 62 urothelial 62 Lymph node 62 AGTR1 62 NP CRNs 62 prognostic indicator 62 prognostic indicators 62 serum HCV RNA 62 tuberculin skin testing 62 underwent surgical resection 62 busulfan 62 ProstaScint 62 carotid artery thickness 62 variant allele 62 bronchoscopies 62 conventional colonoscopy 62 invasive angiography 62 FENO 62 primary aldosteronism 62 antiphospholipid antibodies 62 biochemical relapse 62 myocardial viability 62 test FOBT 62 penetrating keratoplasty 62 pulmonary nodules 62 KRAS mutations 62 cervicovaginal 62 TIMP 62 Histological 62 coronary angiography 62 TRUS biopsy 62 inotropic 62 coronary angiogram 62 haematological 62 sonographic 62 Cystatin C 62 serum phosphorous 62 sympathectomy 62 pheochromocytoma 62 premalignant lesions 62 transrectal 62 core needle biopsies 62 hepatic metastases 62 CD# expression [001] 62 immunoblotting 62 RT PCR assay 62 CD#c 62 perioperative morbidity 62 extracranial 62 atypical ductal hyperplasia 62 eNO 62 abdominal hysterectomy 62 colonoscopy sigmoidoscopy 62 miRview ™ squamous 62 D Dimer 62 plain radiographs 62 invasive carcinoma 62 hepatorenal syndrome 62 cerebral angiography 62 histologic findings 62 submucosal 62 VEGF expression 62 lymphadenopathy 62 endometrial carcinoma 62 hypervascular 62 urinary cytology 62 total thyroidectomy 62 antiandrogens 62 aspartate aminotransferase AST 62 macroalbuminuria 62 carcinoid tumor 62 colorectal polyp 62 neutrophil count 62 sDNA 62 lymph node involvement 62 serological tests 62 electrophysiologic 62 hormone receptor status 62 ALK mutations 62 mediastinal lymph nodes 62 pigmented skin lesions 62 prostate biopsy 62 CT colonography CTC 62 colonoscopic 62 NAbs 62 lymph node metastasis 62 reticulocytes 62 T2 lesions 62 serous ovarian cancer 62 prognostic significance 62 hMG 62 TURP 62 transcranial Doppler ultrasound 62 axillary nodes 62 renal cysts 62 micrometastases 62 pleomorphic 62 precancers 62 vaginal hysterectomy 62 ALA PDT 62 methylated DNA 62 trastuzumab Herceptin ® 62 TIMP 1 62 haematuria 62 baseline LDH 62 Coronary artery calcium 62 mutated K ras 62 creatinine levels 62 androgen ablation 62 FDG PET scans 62 Western blotting 62 prostatic adenocarcinoma 62 Ultrasonography 62 thyroid stimulating hormone 62 postintervention 62 operable breast cancer 62 laser photocoagulation 62 hepatic lesions 62 thyroid carcinoma 62 somatic mutations 62 sonographic appearance 62 diagnosing coronary artery 62 fibroadenomas 62 p = #.# [003] 62 curative resection 62 Haptoglobin 62 NPM1 mutation 62 Zevalin consolidation 62 nonfasting 62 bronchoalveolar lavage BAL 62 MGUS 62 choroidal vasculopathy 62 semiquantitative 62 myocardial revascularization 62 papillary carcinoma 62 surgical excision 62 HbF 62 MR arthrography 62 precancer 62 benign nodules 62 radiochemotherapy 62 multivariable analysis 62 HBeAg seroconversion 62 allogeneic transplant 62 polyp detection 62 antigen PSA levels 62 tryptase 62 intraoperative complications 62 myelofibrosis polycythemia vera 62 non squamous NSCLC 62 hypericin 62 adenoma detection 62 #ng/ml 62 miRview squamous 62 pneumonectomy 62 endoglin 62 endometrial hyperplasia 62 Flow cytometry 62 Multivariate analysis 62 Mantoux test 62 parenchymal 62 hyperinsulinemic euglycemic clamp 61 circulating endothelial cells 61 HER2 ErbB2 61 neoplasia 61 CP CPPS 61 pancreatic lung 61 metachronous 61 sonographic examination 61 axillary node 61 DEXA scans 61 sCJD 61 Epigenomics proprietary 61 clinicopathologic 61 Coronary angiography 61 perfusion MRI 61 situ CIS 61 flutamide 61 antigen PSA 61 gemcitabine Gemzar 61 flexible sigmoidoscopy 61 aneuploidy screening 61 cystectomy 61 Computed tomography 61 latent tuberculosis infection 61 fallopian tube cancers 61 lobular carcinomas 61 carcinoids 61 hydronephrosis 61 nephron sparing surgery 61 #F fluorodeoxyglucose 61 cervical lymph nodes 61 computed tomographic 61 abdominal computed tomography 61 RT qPCR 61 multivariate Cox 61 ^ Tc 61 serum TSH 61 nephrotoxicity 61 LHRH agonists 61 HBeAg 61 biopsied breast 61 pelvic lymph node dissection 61 serum creatinine levels 61 parathyroidectomy 61 clinically insignificant 61 tumor xenograft models 61 carotid artery stenosis 61 neoplasms 61 lavage fluid 61 radiotherapy RT 61 radionuclide imaging 61 enzyme inhibition 61 malignant prostate 61 seminomas 61 Tr DNA 61 mucosal lesions 61 denervation 61 grade squamous intraepithelial 61 nanomolar 61 NPM1 mutations 61 ARB telmisartan 61 apolipoproteins 61 Cardiolite ® 61 chemoembolization 61 microalbumin test 61 X ray angiography 61 pmol L 61 myelodysplastic myeloproliferative diseases 61 renal toxicity 61 gastric adenocarcinoma 61 LH FSH 61 metastatic neuroendocrine tumors 61 BladderChek 61 CC genotype 61 ertapenem 61 preoperative staging 61 percutaneous vertebroplasty 61 bFGF 61 Non inferiority 61 monoinfected patients 61 Septin9 61 mL/min/#.# m 2 61 CIN3 + 61 serum biomarkers 61 invasive ductal 61 F FLT 61 dysplastic nevi 61 gross hematuria 61 Y BOCS 61 adenocarcinomas 61 papillary renal cell carcinoma 61 chemoresistant 61 caspofungin 61 hemoglobin Hb 61 percutaneous biopsy 61 nested PCR 61 metabolic parameters 61 liver biopsies 61 endometrial biopsies 61 cisplatin resistant 61 bladder carcinoma 61 plasma kallikrein inhibitor 61 thickness IMT 61 paraprotein 61 kidney allograft 61 polyp recurrence 61 lung lesions 61 Immunohistochemical analysis 61 CT perfusion 61 nucleotide substitutions 61 logistic regression analyzes 61 endoscopic retrograde 61 CT angiogram 61 pretransplant 61 univariate analysis 61 surgically resectable 61 B Cell Lymphoma 61 LVNC 61 radiofrequency catheter ablation 61 multiple logistic regression 61 mammographic 61 bronchoalveolar 61 monoclonal gammopathy 61 proton MR spectroscopy 61 QTc prolongation 61 transgene expression 61 serum ferritin 61 cystatin C 61 interobserver reliability 61 recurrent glioblastoma multiforme 61 histologic diagnosis 61 VATS lobectomy 61 lung resection 61 Corus CAD 61 liposomal amphotericin B 61 varices 61 DEXA scan 61 FISH fluorescence 61 mammographic density 61 polypoid 61 hyperplastic 61 erythrocyte sedimentation rate 61 conventional Pap smear 61 lesional 61 breast lesions 61 NYHA functional class 61 postoperative radiotherapy 61 metastatic lesions 61 hemodynamically significant 61 oral squamous cell 61 autofluorescence 61 ELISA assays 61 NSCLC tumors 61 BENICAR HCT 61 elevated serum creatinine 61 cerebral microbleeds 61 GSTP1 61 partial nephrectomy 61 Ishak fibrosis score 61 echocardiographic 61 proctitis 61 biochemical abnormalities 61 surrogate markers 61 prognostic markers 61 heterozygotes 61 paclitaxel eluting stents 61 MDCT angiography 61 sleeve lobectomy 61 isoenzyme 61 Fecal occult blood 61 leukocyte count 61 HLA DQ 61 Preoperative 61 obstructive coronary artery 61 murine model 61 multivariate regression analysis 61 DXA scan 61 MDRD equation 61 computed tomography SPECT 61 electron beam computed tomography 61 rebleeding 61 Cardiotoxicity 61 5alpha reductase 61 serum aminotransferase levels 61 neutrophil counts 61 Alkaline Phosphatase 61 perioperatively 61 thoracoscopic lobectomy 61 maternal serum 61 IV bisphosphonates 61 Hypotension 61 Kruskal Wallis test 61 transaminases 61 histopathologic diagnosis 61 prognostic marker 61 radical prostatectomy RP 61 adenoma 61 thermogram 61 intensive statin therapy 61 positron emission 61 TT genotype 61 fluorescence detection 61 MAGE A3 ASCI 61 situ hybridization 61 Response Evaluation Criteria 61 Bonferroni 61 Chlamydia pneumoniae 61 ERBB2 61 pretargeting 61 lung metastasis 61 inhibin B 60 serum lipid 60 glutamic acid decarboxylase 60 BSGI MBI 60 GISTs 60 carotid bruit 60 tracer uptake 60 malignant lymphoma 60 paragangliomas 60 QuantiFERON TB Gold 60 sentinel lymph nodes 60 thyroid peroxidase 60 intravitreal injections 60 gadobutrol 60 ribavirin therapy 60 PET CT scans 60 T#I [002] 60 monophasic 60 Cystectomy 60 cervical intraepithelial neoplasia 60 seropositivity 60 alkylating agent 60 liver biopsy 60 mesenteric 60 PCA3 60 morphologic 60 thyrotropin 60 clinically localized prostate 60 fine needle aspirate 60 lymph node biopsies 60 adnexal masses 60 dimeglumine 60 subgroup analyzes 60 Magnetic resonance 60 chest radiograph 60 paricalcitol 60 hamartoma 60 lung carcinomas 60 nondiabetic patients 60 nodal dissection 60 magnetic resonance angiography 60 PCR amplification 60 sulfasalazine 60 graft occlusion 60 fluvastatin 60 colposcopic 60 -#.# ± [002] 60 GnRH agonists 60 mediastinal 60 salpingo oophorectomy 60 Clusterin 60 cytotoxic therapy 60 diagnostic angiography 60 OvaRex MAb 60 Liver biopsy 60 subclinical hyperthyroidism 60 pre malignant lesions 60 periprocedural 60 EGFR expression 60 antiangiogenic agent 60 activated partial thromboplastin 60 NMP# BladderChek Test 60 carotid plaque 60 central corneal thickness 60 anterior uveitis 60 adrenocortical 60 asymptomatic carotid stenosis 60 bovine thrombin 60 diabetes mellitus DM 60 undetectable HBV DNA 60 cardiac magnetic resonance 60 ATACAND 60 virologic responses 60 % CI #.#-#.# [005] 60 sonographic diagnosis 60 intravenous bisphosphonates 60 Intravenous immunoglobulin 60 nonischemic 60 hemodilution 60 stage IIIb IV 60 incisional biopsy 60 BRAF mutations 60 alteplase 60 chronic eosinophilic leukemia 60 EDEMA3 trial 60 #m Tc 60 paroxysmal AF 60 prostate cancer PCa 60 coronary stenoses 60 distant metastasis 60 osteosarcomas 60 chemiluminescence 60 mediastinitis 60 seronegative 60 selenium supplementation 60 vimentin 60 APOE e4 60 TRAIL R1 60 PAOD 60 APTIMA HPV 60 nonsmall cell lung cancer 60 ELISA enzyme 60 PSA kinetics 60 dosimetric 60 antibiotic regimens 60 Angiographic 60 fluorescein angiography 60 papillary thyroid carcinoma 60 HoLEP 60 Circulating tumor cells 60 oxyhemoglobin 60 prostate specific 60 endometrial cancers 60 x ray angiography 60 mRNA expression 60 leukopenia 60 plasma pharmacokinetics 60 endoscopic examinations 60 Bone density 60 pancreatic adenocarcinoma 60 methotrexate therapy 60 beta blocker therapy 60 polycythemia vera PV 60 ALT normalization 60 neurocognitive function 60 bezafibrate 60 splenic 60 kidney cysts 60 ALT flares 60 nomograms 60 androgen deprivation 60 Naive Patients 60 gonococcal infections 60 antitumor effect 60 gastric carcinoma 60 hyperacute 60 VKORC1 60 colorectal adenocarcinoma 60 HbA1C 60 HbA 1c levels 60 obstructive coronary 60 T2 weighted images 60 skeletal metastases 60 QuantiFERON 60 glomerular filtration rate 60 nephrogenic 60 Specificity 60 HIV tropism 60 tumor necrosis 60 neoadjuvant chemotherapy 60 NPM1 60 proximal colon 60 hypermethylated 60 echocardiographic parameters 60 ablative therapy 60 Tumor Response 60 coronary artery stenosis 60 pleurodesis 60 creatine kinase MB 60 TOP2A gene 60 PITX2 60 hepatic enzyme 60 hemorrhagic complications 60 perimenopausal women 60 T1a 60 transurethral 60 plasma creatinine 60 invasive aspergillosis 60 neutropaenia 60 genitourinary cancers 60 chemoradiotherapy 60 thyrotropin levels 60 pericardial effusion 60 seminal vesicle invasion 60 spectrophotometric 60 preoperative evaluation 60 ductal lobular 60 carcinoid 60 transferrin saturation 60 contralateral breast 60 corticosteroid therapy 60 immunosuppressant therapy 60 serrated polyps